Atlas Trials

Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393

Clinical trial NCT05113693 · COMPLETED

Trial details

NCT number
NCT05113693
Sponsor
Chong Kun Dang Pharmaceutical
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2021-11-25
Primary completion
2021-12-06
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.